A carregar...
Immunotherapeutic and Targeted Approaches in Multiple Myeloma
The multiple myeloma (MM) therapeutic landscape has evolved significantly with the approval of numerous novel agents, including next generation proteasome inhibitors (PIs), immunomodulatory agents (IMIDs), and monoclonal antibodies (MoABs) targeting CD38 and SLAMF7. While these discoveries have led...
Na minha lista:
| Publicado no: | Immunotargets Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7569026/ https://ncbi.nlm.nih.gov/pubmed/33117743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S240886 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|